Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05331690
Other study ID # 93944
Secondary ID 2020-003407-34
Status Recruiting
Phase Phase 4
First received
Last updated
Start date November 25, 2022
Est. completion date December 2023

Study information

Verified date November 2022
Source Oslo University Hospital
Contact Olav Kristianslund, MD PhD
Phone +4722118545
Email olakri@ous-hf.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The pre-CIN trial is a randomized clinical three-arm trial comparing inflammation and cystoid macular edema for the medication regimens preoperative and postoperative topical NSAIDs to only postoperative topical NSAIDs to postoperative topical NSAIDs and steroids in patients undergoing cataract surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date December 2023
Est. primary completion date August 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients must be 18 years and older at the time of the signing of the informed consent. There is no upper age limit. - Scheduled for standard phacoemulsification cataract surgery (group 1 - 3) - Scheduled for combined phacoemulsification cataract surgery and MIGS stent (group 4) - Ability to cooperate fairly well during the examinations - Willing to participate in the study and capable of giving informed consent, which includes compliance with the requirements and restrictions in the informed consent form (ICF) and in this protocol. Exclusion Criteria: - Contraindications for use of any medication (as listed in the approved SPC, e.g. allergy, pregnancy, breastfeeding) - Pregnancy - Diabetes - Mature cataract - Active or chronic uveitis with recommendation for steroid treatment - Previous trabeculectomy - Other ophthalmological conditions and/or complicating factors requiring steroid treatment (group 1 - 3) - Cornea pathology requiring specific medication regimens (e.g. herpes pathology, previous corneal transplantation) Patients with complications or other complicating factors during surgery that causes the surgeon to demand both NSAIDs and steroid treatment will be excluded from the main analysis. These patients will be followed postoperatively as part of the study and included in additional analyses (for example as part of an intention to treat analysis). For patients scheduled for cataract surgery in both eyes, only the first operated eye will be included, however, both eyes will be examined.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Nepafenac Ophthalmic
Topical nepafenac (Nevanac) 3 mg/ml starter the day before surgery
Nepafenac Ophthalmic
Topical nepafenac (Nevanac) 3 mg/ml started the day after surgery
Dexamethasone Ophthalmic
Topical dexamethasone 1 mg/ml (Spersadex) started the day after surgery

Locations

Country Name City State
Norway Department of Ophthalmology, Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Central macular thickness after 6 weeks Measure central macular thickness (in um) on optical coherence tomography (OCT) 6 weeks after surgery
Primary Cystoid macular edema (CME) after 6 weeks Determine if the patient has CME based on evaluation of macular cysts on optical coherence tomography (OCT) 6 weeks after surgery
Secondary Intraocular inflammation Measured by laser flare meter Preoperatively, and 1 week, 6 weeks, 6 months after surgery
Secondary Visual outcome Measure uncorrected and corrected distance visual acuity using visual acuity chart Preoperatively, and 1 week, 6 weeks, 6 months after surgery
Secondary Intraocular pressure Measured by tonometry Preoperatively, and 1 week, 6 weeks, 6 months after surgery
Secondary Central macular thickness (CMT) Measure CMT (in um) on optical coherence tomography (OCT) Preoperatively, 1 week, and 6 months after surgery
Secondary Cystoid macular edema (CME) Determine if the patient has CME based on evaluation of macular cysts on optical coherence tomography (OCT) Preoperatively, 1 week, and 6 months after surgery
See also
  Status Clinical Trial Phase
Completed NCT02573610 - Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery Phase 3
Completed NCT02910362 - Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines N/A
Recruiting NCT01193504 - Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification Phase 4
Completed NCT01455233 - 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery Phase 4
Completed NCT01199510 - Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery Phase 4
Completed NCT04146961 - The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
Completed NCT00585975 - Efficacy and Safety of Bromfenac Ophthalmic Solution Phase 2
Completed NCT00406913 - Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery N/A
Not yet recruiting NCT04131335 - Use of Prophylactic Lubricating Drops After Cataract Surgery N/A
Withdrawn NCT04563559 - PREFERENTIAL Study Phase 2/Phase 3
Completed NCT04732351 - Evaluation of the Active Sentry System During Cataract Surgery With the Centurion Phacoemulsifier
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT03873454 - The Effects of Music on Perioperative Outcomes in Cataract Surgery N/A
Completed NCT04769856 - Impact of Non-fasting on Anxiety in Cataract Surgery N/A
Withdrawn NCT00604305 - Comperative Trial Between an Accommodative Iol and Monofocal Iol N/A
Completed NCT05925894 - Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma. N/A
Not yet recruiting NCT06136780 - Impact of Free Reading Glasses on Work and Visual Function Following Cataract Surgery in Honduras N/A
Completed NCT04633954 - Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery N/A
Completed NCT03644875 - Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
Recruiting NCT04781231 - Impact of Music Added to the Usual Treatment on the Anxiety of Patients Undergoing Outpatient Cataract Surgery With Topical Anesthesia N/A